These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 9445175)

  • 1. Toward a new frontier in myocardial reperfusion therapy: emerging platelet preeminence.
    Topol EJ
    Circulation; 1998 Jan; 97(2):211-8. PubMed ID: 9445175
    [No Abstract]   [Full Text] [Related]  

  • 2. Combination fibrinolytic therapy and platelet glycoprotein IIb/IIIa receptor blockade in acute myocardial infarction: an emerging solution for reperfusion.
    Kaplan AL; Goldmann B; Ohman EM
    J Emerg Med; 1999; 17(3):589-95. PubMed ID: 10338261
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacological reperfusion in acute myocardial infarction after ASSENT 3 and GUSTO V.
    Ferreira D
    Rev Port Cardiol; 2003; 22(7-8):1005-9. PubMed ID: 14587168
    [No Abstract]   [Full Text] [Related]  

  • 4. [Reperfusion after acute myocardial infarct with fibrinolytic therapy o combination reduced fibrinolytic therapy and a glycoprotein IIb/IIIa inhibitor: the GUSTO V study].
    Franzosi MG
    Ital Heart J Suppl; 2001 Sep; 2(9):1034-6. PubMed ID: 11675828
    [No Abstract]   [Full Text] [Related]  

  • 5. The use of glycoprotein IIb/IIIa inhibitor therapy in acute ST-segment elevation myocardial infarction: current practice and future trends.
    Campbell KR; Ohman EM; Cantor W; Lincoff AM
    Am J Cardiol; 2000 Apr; 85(8A):32C-8C. PubMed ID: 10793178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Present and potential future paradigms for the treatment of ST-segment elevation acute myocardial infarction.
    Chew DP; Moliterno DJ; Herrmann HC
    J Invasive Cardiol; 2002 Feb; 14 Suppl A():3A-20A. PubMed ID: 11847402
    [No Abstract]   [Full Text] [Related]  

  • 7. Glycoprotein IIb/IIIa antagonist and fibrinolytic agents: new therapeutic regimen for acute myocardial infarction.
    Patel VB; Moliterno DJ
    J Invasive Cardiol; 2000 Mar; 12 Suppl B():8B-15B. PubMed ID: 10731294
    [No Abstract]   [Full Text] [Related]  

  • 8. Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial.
    Topol EJ;
    Lancet; 2001 Jun; 357(9272):1905-14. PubMed ID: 11425410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overview of the use of glycoprotein IIb/IIIa inhibitors in acute myocardial infarction.
    Joseph A
    J Emerg Med; 1999; 17(3):567-73. PubMed ID: 10338258
    [No Abstract]   [Full Text] [Related]  

  • 10. Sonothrombolysis: a universally applicable and better way to treat acute myocardial infarction and stroke? Who is going to fund the research?
    Kaul S
    Circulation; 2009 Mar; 119(10):1358-60. PubMed ID: 19255337
    [No Abstract]   [Full Text] [Related]  

  • 11. [Combination therapy for acute myocardial infarction with glycoprotein IIb/IIIa inhibitors and fibrinolysis].
    Ottani F; Bresciani B; La Vecchia L; Favero L; Fontanelli A; Galvani M
    Ital Heart J Suppl; 2002 May; 3(5):544-54. PubMed ID: 12064194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial.
    Pereira H;
    Rev Port Cardiol; 2001 Jun; 20(6):687-8. PubMed ID: 11525077
    [No Abstract]   [Full Text] [Related]  

  • 13. Current perspectives on reperfusion therapy for acute ST-segment elevation myocardial infarction: integrating pharmacologic and mechanical reperfusion strategies.
    Waters RE; Mahaffey KW; Granger CB; Roe MT
    Am Heart J; 2003 Dec; 146(6):958-68. PubMed ID: 14660986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet GPIIb/IIIa receptor blockers for failed thrombolysis in acute myocardial infarction, alone or as adjunct to other rescue therapies.
    Mahadevan VS; McCarty D; Adgey AA
    Eur Heart J; 2002 Oct; 23(19):1490-1. PubMed ID: 12242068
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacoinvasive therapy: the future of treatment for ST-elevation myocardial infarction.
    Antman EM; Van de Werf F
    Circulation; 2004 Jun; 109(21):2480-6. PubMed ID: 15173037
    [No Abstract]   [Full Text] [Related]  

  • 16. Rise and fall of glycoprotein IIb-IIIa inhibitors in ST-segment elevation myocardial infarction.
    Di Mario C
    Heart; 2014 Jun; 100(11):823-4. PubMed ID: 24659350
    [No Abstract]   [Full Text] [Related]  

  • 17. Achieving tissue-level perfusion in the setting of acute myocardial infarction.
    Mukherjee D; Moliterno DJ
    Am J Cardiol; 2000 Apr; 85(8A):39C-46C. PubMed ID: 10793179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined assessment of thrombolysis in myocardial infarction flow grade, myocardial perfusion grade, and ST-segment resolution to evaluate epicardial and myocardial reperfusion.
    Giugliano RP; Sabatine MS; Gibson CM; Roe MT; Harrington RA; Murphy SA; Morrow DA; Antman EM; Braunwald E
    Am J Cardiol; 2004 Jun; 93(11):1362-7, A5-6. PubMed ID: 15165915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. STEMI interventions--a review of relevant clinical trials.
    Mehta S; Patlola RR; Cohen S; Falcao E; Flores AI; Soles EO
    Indian Heart J; 2009; 61(2):191-206. PubMed ID: 20039507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Strategies to improve reperfusion with fibrinolytic therapy in ST-T elevation myocardial infarction].
    Jerjes-Sánchez C; Sosa del Angel E; García Sosa A; Reyes Cerezo E; Garza Ruiz A
    Arch Cardiol Mex; 2003; 73(1):46-58. PubMed ID: 12820494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.